- In January 2023, Royal Queen Seeds became the pioneer in supplying true F1 cannabis hybrids, offering uniformity, stability, and high yield quality for the emerging legal cannabis market. Their RQS F1 seeds, derived from inbred lines, aim to revolutionize the industry by ensuring consistent crops and standardized final products
- In September 2022, CBD Seed Europe, a Bulgarian company, registered two genotypes on the European Seed Register, boasting record levels of cannabidiol. These cultivars, "Midwest" and "Northwest," promise CBD concentrations of up to 12%, exceeding the typical 5% to 6% found in most registered CBD seeds
- In 2021, Germany's STADA Arzneimittel AG ventured into the medical cannabis market through a strategic partnership with Canadian firm MediPharm Labs. This collaboration underscores the pharmaceutical industry's recognition of the expanding market for medical cannabis products, adapting to evolving consumer demands and regulatory frameworks in Germany
- In 2020, MedPharm collaborated with CBD Vida, Ltda to launch CBD CALM in Brazil, showcasing the global expansion of the medical cannabis market. Through partnerships such as these, companies aim to address the increasing demand for medical cannabis worldwide while diversifying their product offerings to cater to different region
